Globus Medical (GMED) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Globus Medical Reports Second Quarter 2017 Results
August 2, 2017 4:30 PM EDTAUDUBON, Pa., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions manufacturer, today announced its financial results for the second quarter ended June 30, 2017.
Worldwide sales were $152.4 million, an increase of 10.8% as reported, or 11.0% in constant currencySecond quarter net income was $28.7 million, or 18.8% of salesDiluted earnings per share (EPS) were $0.29Non-GAAP diluted EPS were $0.32Non-GAAP adjusted EBITDA was 35.1% of salesDavid Paul, Chairman and CEO said, Our worldwide sales for the second quarter were $152.4 million, an increase of 10.8%... More
